Journal Home
Search for

Volume 47, Issue 2, Pages 388-394 (February 2008)


View previous. 29 of 63 View next.

Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients

Hyun S. Kim, MDabCorresponding Author Informationemail address, Stephen R. Preece, BAa, James H. Black, MDb, Luu D. Pham, MAc, Michael B. Streiff, MDd

Received 23 July 2007; accepted 20 October 2007.

Background

The current study was conducted to demonstrate that catheter-directed thrombolysis for upper and lower extremity deep vein thrombosis is equally safe in patients with and without cancer.

Methods

A retrospective cohort of consecutive patients with acute iliofemoral or brachiosubclavian deep vein thrombosis treated with catheter-directed thrombolysis was identified. Demographic characteristics and clinical outcomes were compared between patients with cancer and without cancer.

Results

Catheter-directed thrombolysis was used to treat 202 limbs in 178 patients (75 limbs in 61 cancer patients and 127 limbs in 117 patients without cancer). The mean treatment duration for patients with cancer (29.7 ± 21.2 hours) and without cancer (28.8 ± 22.2 hours) was similar (P = .7774). Catheter-directed thrombolysis achieved grade III clot lysis in a similar proportion of cancer patients (50 of 75 limbs, 66.7%) and patients without cancer (82 of 127 limbs, 64.6%; P = .7619). Grade II clot lysis also was achieved in equal numbers of patients with (20 of 75 limbs, 26.7%) and without cancer (34 of 127 limbs, 26.8%; P = .9872). Three cancer patients (4.9%) and four noncancer patients (3.4%) experienced major bleeding during catheter-directed thrombolysis (P = .6924). Pulmonary embolism occurred in 1.6% (1 of 61) of cancer patients and in 1.7% (2 of 117) of patients without cancer (P = .9999) during catheter-directed thrombolysis. Patients aged ≥70 years had an increased risk of major bleeding.

Conclusion

Percutaneous catheter-directed thrombolysis is equally safe for patients with and without cancer who have acute symptomatic deep vein thrombosis.

a Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore Md

b Department of Surgery, Johns Hopkins University School of Medicine, Baltimore Md

c Department of Biostatistics, Johns Hopkins University School of Medicine, Baltimore Md

d Department of Medicine, Johns Hopkins University School of Medicine, Baltimore Md.

Corresponding Author InformationReprint requests: Hyun S. Kim, MD, 600 N Wolfe St, Blalock 545, Division of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21287-4010.

 Competition of interest: none.

PII: S0741-5214(07)01694-1

doi:10.1016/j.jvs.2007.10.033


View previous. 29 of 63 View next.